4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
4.38
-0.01 (-0.23%)
At close: Jun 16, 2025, 3:59 PM
4.58
4.57%
After-hours: Jun 16, 2025, 07:27 PM EDT
-0.23% (1D)
| Bid | 3.69 |
| Market Cap | 202.9M |
| Revenue (ttm) | 9K |
| Net Income (ttm) | -176.44M |
| EPS (ttm) | -3.18 |
| PE Ratio (ttm) | -1.38 |
| Forward PE | -1.14 |
| Analyst | Buy |
| Ask | 4.7 |
| Volume | 238,865 |
| Avg. Volume (20D) | 608,984 |
| Open | 4.51 |
| Previous Close | 4.39 |
| Day's Range | 4.28 - 4.51 |
| 52-Week Range | 2.23 - 28.93 |
| Beta | 2.83 |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-13.91%
4D Molecular Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
5 months ago
-13.77%
4D Molecular Therapeutics shares are trading lower after Leerink Partners and Morgan Stanley cut their respective price targets on the stock.
